A Study of Belimumab in Chinese Pediatric Participants With Systemic Lupus Erythematosus
NCT05917288
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Systemic Lupus Erythematosus
Interventions
BIOLOGICAL:
Belimumab
DRUG:
Standard of care
Sponsor
GlaxoSmithKline